Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence

Trends in Biochemical Sciences

Volumn 39, Issue 6, 2014, Pages 268-276

  Xu, Yingxi ^a,b   Li, Na ^a   Xiang, Rong ^a   Sun, Peiqing ^b  

^a NANKAI UNIVERSITY   (China)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

AKT; Oncogene induced senescence; P38; Phosphoinositide 3 kinase

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN REGULATED ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TAT INTERACTIVE PROTEIN 60 KDA; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; TARGET OF RAPAMYCIN KINASE;

CANCER INHIBITION; CELL CYCLE REGULATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; DISEASE COURSE; DNA DAMAGE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; NONHUMAN; ONCOGENE INDUCED SENESCENCE; ONCOLOGICAL PARAMETERS; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REVIEW; SECRETORY PATHWAY; SENESCENCE ASSOCIATED SECRETORY PHENOTYPE; SIGNAL TRANSDUCTION; ANIMAL; CELL AGING; GENETICS; METABOLISM; ONCOGENE;

MURINAE;

ANIMALS; CELL AGING; HUMANS; ONCOGENES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84901231782     PISSN: 09680004     EISSN: 13624326     Source Type: Journal    
DOI: 10.1016/j.tibs.2014.04.004     Document Type: Review

References (72)

1. Hayflick L. Living forever and dying in the attempt. Exp. Gerontol. 2003, 38:1231-1241.
2. Shay J.W., Wright W.E. Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis 2005, 26:867-874.
3. Serrano M., et al. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997, 88:593-602.
4. Wei S., et al. Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts. Cancer Res. 1999, 59:1539-1543.
5. Suram A., et al. Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions. EMBO J. 2012, 31:2839-2851.
6. Courtois-Cox S., et al. Many roads lead to oncogene-induced senescence. Oncogene 2008, 27:2801-2809.
7. Lin A.W., et al. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 1998, 12:3008-3019.
8. Lee A.C., et al. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J. Biol. Chem. 1999, 274:7936-7940.
9. Bartkova J., et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006, 444:633-637.
10. Di Micco R., et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006, 444:638-642.
11. Adams P.D. Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene 2007, 397:84-93.
12. Freund A., et al. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol. Med. 2010, 16:238-246.
13. Kuilman T., et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008, 133:1019-1031.
14. Wajapeyee N., et al. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 2008, 132:363-374.
15. Acosta J.C., et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 2008, 133:1006-1018.
16. Yang G., et al. The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:16472-16477.
17. Xue W., et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007, 445:656-660.
18. Krizhanovsky V., et al. Senescence of activated stellate cells limits liver fibrosis. Cell 2008, 134:657-667.
19. Freund A., et al. p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J. 2011, 30:1536-1548.
20. Wang W., et al. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol. Cell. Biol. 2002, 22:3389-3403.
21. Iwasa H., et al. Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes Cells 2003, 8:131-144.
22. Bulavin D.V., et al. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat. Genet. 2002, 31:210-215.
23. Bulavin D.V., et al. Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a. Mol. Cell. Biol. 2003, 23:3859-3871.
24. Kwong J., et al. p38alpha and p38gamma mediate oncogenic ras-induced senescence through differential mechanisms. J. Biol. Chem. 2009, 284:11237-11246.
25. Kwong J., et al. Induction of p38delta expression plays an essential role in oncogenic ras-induced senescence. Mol. Cell. Biol. 2013, 33:3780-3794.
26. Zhu J., et al. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 1998, 12:2997-3007.
27. Shin J., et al. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence. Cell. Signal. 2013, 25:2540-2547.
28. Zdanov S., et al. Identification of p38MAPK-dependent genes with changed transcript abundance in H2O2-induced premature senescence of IMR-90 hTERT human fibroblasts. FEBS Lett. 2006, 580:6455-6463.
29. Colavitti R., Finkel T. Reactive oxygen species as mediators of cellular senescence. IUBMB Life 2005, 57:277-281.
30. Nicke B., et al. Involvement of MINK, a Ste20 family kinase, in Ras oncogene-induced growth arrest in human ovarian surface epithelial cells. Mol. Cell 2005, 20:673-685.
31. Dolado I., et al. p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis. Cancer Cell 2007, 11:191-205.
32. Kodama R., et al. ROS-generating oxidases Nox1 and Nox4 contribute to oncogenic Ras-induced premature senescence. Genes Cells 2013, 18:32-41.
33. Wang X., et al. Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest. Mol. Cell. Biol. 2000, 20:4543-4552.
34. Ogrunc M., et al. Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation. Cell Death Differ. 2014, 10.1038/cdd.2014.16.
35. Passos J.F., et al. Feedback between p21 and reactive oxygen production is necessary for cell senescence. Mol. Syst. Biol. 2010, 6:347.
36. Bulavin D.V., et al. Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J. 1999, 18:6845-6854.
37. Xiu M., et al. The transcriptional repressor HBP1 is a target of the p38 mitogen-activated protein kinase pathway in cell cycle regulation. Mol. Cell. Biol. 2003, 23:8890-8901.
38. Zhang X., et al. The HBP1 transcriptional repressor participates in RAS-induced premature senescence. Mol. Cell. Biol. 2006, 26:8252-8266.
39. Li H., et al. Transcriptional factor HBP1 targets P16(INK4A), upregulating its expression and consequently is involved in Ras-induced premature senescence. Oncogene 2010, 29:5083-5094.
40. Sun P., et al. PRAK is essential for ras-induced senescence and tumor suppression. Cell 2007, 128:295-308.
41. New L., et al. PRAK, a novel protein kinase regulated by the p38 MAP kinase. EMBO J. 1998, 17:3372-3384.
42. Zheng H., et al. A posttranslational modification cascade involving p38, Tip60, and PRAK mediates oncogene-induced senescence. Mol. Cell 2013, 50:699-710.
43. Sapountzi V., et al. Cellular functions of TIP60. Int. J. Biochem. Cell Biol. 2006, 38:1496-1509.
44. Squatrito M., et al. Tip60 in DNA damage response and growth control: many tricks in one HAT. Trends Cell Biol. 2006, 16:433-442.
45. Gorrini C., et al. Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response. Nature 2007, 448:1063-1067.
46. Charvet C., et al. Phosphorylation of Tip60 by GSK-3 determines the induction of PUMA and apoptosis by p53. Mol. Cell 2011, 42:584-596.
47. Tang Y., et al. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol. Cell 2006, 24:827-839.
48. Ventura J.J., et al. p38alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat. Genet. 2007, 39:750-758.
49. Hui L., et al. p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway. Nat. Genet. 2007, 39:741-749.
50. Yoshizuka N., et al. PRAK suppresses oncogenic ras-induced hematopoietic cancer development by antagonizing the JNK pathway. Mol. Cancer Res. 2012, 10:810-820.
51. Bulavin D.V., et al. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat. Genet. 2004, 36:343-350.
52. Demidov O.N., et al. The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis. Oncogene 2006, 26:2502-2506.
53. Tront J.S., et al. Gadd45a suppresses Ras-driven mammary tumorigenesis by activation of c-Jun NH2-terminal kinase and p38 stress signaling resulting in apoptosis and senescence. Cancer Res. 2006, 66:8448-8454.
54. Iyoda K., et al. Involvement of the p38 mitogen-activated protein kinase cascade in hepatocellular carcinoma. Cancer 2003, 97:3017-3026.
55. Rauta J., et al. The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours. Breast Cancer Res. Treat. 2006, 95:257-263.
56. Engelman J.A., et al. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 2006, 7:606-619.
57. Miyauchi H., et al. Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway. EMBO J. 2004, 23:212-220.
58. Chen Z., et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005, 436:725-730.
59. Astle M.V., et al. AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy. Oncogene 2012, 31:1949-1962.
60. Kolesnichenko M., et al. Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence. Cell Cycle 2012, 11:2391-2401.
61. Alimonti A., et al. A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis. J. Clin. Invest. 2010, 120:681-693.
62. Bassi C., et al. Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress. Science 2013, 341:395-399.
63. Vredeveld L.C., et al. Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis. Genes Dev. 2012, 26:1055-1069.
64. Bianchi-Smiraglia A., Nikiforov M.A. Controversial aspects of oncogene-induced senescence. Cell Cycle 2012, 11:4147-4151.
65. Ono K., Han J. The p38 signal transduction pathway: activation and function. Cell. Signal. 2000, 12:1-13.
66. Lu G., et al. TAB-1 modulates intracellular localization of p38 MAP kinase and downstream signaling. J. Biol. Chem. 2006, 281:6087-6095.
67. Shi Y., Gaestel M. In the cellular garden of forking paths: how p38 MAPKs signal for downstream assistance. Biol. Chem. 2002, 383:1519-1536.
68. Bulavin D.V., Fornace A.J. p38 MAP kinase's emerging role as a tumor suppressor. Adv. Cancer Res. 2004, 92:95-118.
69. Han J., Sun P. The pathways to tumor suppression via route p38. Trends Biochem. Sci. 2007, 32:364-371.
70. Yoshizuka N., et al. A novel function of p38-regulated/activated kinase in endothelial cell migration and tumor angiogenesis. Mol. Cell. Biol. 2012, 32:606-618.
71. Zhao L., Vogt P.K. Class I PI3K in oncogenic cellular transformation. Oncogene 2008, 27:5486-5496.
72. Polivka J., Janku F. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol. Ther. 2013, 142:164-175.